HPV jabs for boys 'not cost-effective'

Offering the HPV jab to boys would not prove to be cost-effective if there is a high enough uptake among girls, say US researchers.

Photograph:A.DEX,PUBLIPHOTO DIFFUSION/SPL
Photograph:A.DEX,PUBLIPHOTO DIFFUSION/SPL

Latest figures from the NHS Information Centre show that 70% of eligible 12 to 13 year-old girls received all three doses, and 87% one dose, in 2008/9.

However, future uptake levels could be hit after a 14-year old girl died shortly after receiving a HPV jab at school. A post-mortem has since revealed that the death was not cause by a reaction to the jab but by a malignant tumour.

Earlier this year, experts warned that the DoH may be forced to add boys to the HPV vaccination programme in order to hit the uptake levels required for herd immunity.

For this latest study, researchers from Harvard University in Boston conducted a cost-effectiveness analysis to compare HPV vaccination of pre-adolescent girls alone with vaccination of both girls and boys.

Vaccination was considered to be value for money if the quality-adjusted life year (QALY) was in the range of £31,172 to £62,344.

Overall, they found that while the vaccination of 12-year-old girls was cost-effective, including boys into the vaccination programme surpassed the upper QALY threshold.

The researchers concluded: ‘Our results suggest that if vaccine coverage and efficacy are high among preadolescent girls, including boys in an HPV programme is unlikely to provide comparatively good value for resources.'

 

 

GP Online recommends

BMJ online

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

First COVID-19 jabs to target care home residents and staff under new JCVI advice

First COVID-19 jabs to target care home residents and staff under new JCVI advice

Older adults living in care homes and staff working there will be first to receive...

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs facing fitness to practise investigations during the COVID-19 pandemic will be...

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

A government review has rejected calls for a major overhaul of an NHS Property Services...

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

The RCGP and the Royal Pharmaceutical Society have called on GP practices and community...

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments have risen rapidly in recent weeks as schools returned, according...

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

Medical training and the future NHS workforce could be seriously damaged by the financial...